<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">
<PubmedArticleSet>
<PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM">
        <PMID Version="1">17990895</PMID>
        <DateCompleted>
            <Year>2008</Year>
            <Month>02</Month>
            <Day>20</Day>
        </DateCompleted>
        <DateRevised>
            <Year>2019</Year>
            <Month>10</Month>
            <Day>03</Day>
        </DateRevised>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Print">0022-3263</ISSN>
                <JournalIssue CitedMedium="Print">
                    <Volume>72</Volume>
                    <Issue>25</Issue>
                    <PubDate>
                        <Year>2007</Year>
                        <Month>Dec</Month>
                        <Day>07</Day>
                    </PubDate>
                </JournalIssue>
                <Title>The Journal of organic chemistry</Title>
                <ISOAbbreviation>J Org Chem</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Structural examination of ring-closing metathesis-derived 15-member macrocycles as Grb2 SH2 domain-binding tetrapeptide mimetics.</ArticleTitle>
            <Pagination>
                <MedlinePgn>9635-42</MedlinePgn>
            </Pagination>
            <Abstract>
                <AbstractText>Ring-closing metathesis (RCM) was employed to join carboxy-terminal alkenyl glycine side chains together with vinyl- and allyl-functionality appended to the beta-methylene of amino-terminal phosphotyrosyl (pTyr) mimetics. This required the synthesis of a variety of new pTyr mimetics, including a novel aza-containing analogue. Many of the resulting 15-member macrocyclic tetrapeptide mimetics exhibited low nanomolar Grb2 SH2 domain-binding affinities in spite of the fact that differing ring junction stereochemistries and geometries of the RCM-derived double bond were employed. The finding that significant latitude exists in the structural requirements for ring closure may facilitate the development of therapeutically relevant macrocyle-based Grb2 SH2 domain-binding antagonists. The synthetic approaches used in this study may also find application to peptide mimetics directed at other biological targets.</AbstractText>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Liu</LastName>
                    <ForeName>Fa</ForeName>
                    <Initials>F</Initials>
                    <AffiliationInfo>
                        <Affiliation>Laboratory of Medicinal Chemistry, CCR, NCI, NIH, Frederick, Maryland 21702, USA.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Worthy</LastName>
                    <ForeName>Karen M</ForeName>
                    <Initials>KM</Initials>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Bindu</LastName>
                    <ForeName>Lakshman K</ForeName>
                    <Initials>LK</Initials>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Fisher</LastName>
                    <ForeName>Robert J</ForeName>
                    <Initials>RJ</Initials>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Burke</LastName>
                    <ForeName>Terrence R</ForeName>
                    <Initials>TR</Initials>
                    <Suffix>Jr</Suffix>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <GrantList CompleteYN="Y">
                <Grant>
                    <GrantID>N01CO12400</GrantID>
                    <Acronym>CA</Acronym>
                    <Agency>NCI NIH HHS</Agency>
                    <Country>United States</Country>
                </Grant>
                <Grant>
                    <GrantID>Z01 BC006198-18</GrantID>
                    <Agency>Intramural NIH HHS</Agency>
                    <Country>United States</Country>
                </Grant>
                <Grant>
                    <GrantID>N01-CO-12400</GrantID>
                    <Acronym>CO</Acronym>
                    <Agency>NCI NIH HHS</Agency>
                    <Country>United States</Country>
                </Grant>
            </GrantList>
            <PublicationTypeList>
                <PublicationType UI="D016428">Journal Article</PublicationType>
                <PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType>
                <PublicationType UI="D052060">Research Support, N.I.H., Intramural</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2007</Year>
                <Month>11</Month>
                <Day>09</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>United States</Country>
            <MedlineTA>J Org Chem</MedlineTA>
            <NlmUniqueID>2985193R</NlmUniqueID>
            <ISSNLinking>0022-3263</ISSNLinking>
        </MedlineJournalInfo>
        <ChemicalList>
            <Chemical>
                <RegistryNumber>0</RegistryNumber>
                <NameOfSubstance UI="D051380">GRB2 Adaptor Protein</NameOfSubstance>
            </Chemical>
            <Chemical>
                <RegistryNumber>0</RegistryNumber>
                <NameOfSubstance UI="D047028">Macrocyclic Compounds</NameOfSubstance>
            </Chemical>
            <Chemical>
                <RegistryNumber>0</RegistryNumber>
                <NameOfSubstance UI="D009842">Oligopeptides</NameOfSubstance>
            </Chemical>
        </ChemicalList>
        <CitationSubset>IM</CitationSubset>
        <MeshHeadingList>
            <MeshHeading>
                <DescriptorName UI="D001665" MajorTopicYN="N">Binding Sites</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D003500" MajorTopicYN="N">Cyclization</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D051380" MajorTopicYN="N">GRB2 Adaptor Protein</DescriptorName>
                <QualifierName UI="Q000737" MajorTopicYN="Y">chemistry</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D047028" MajorTopicYN="N">Macrocyclic Compounds</DescriptorName>
                <QualifierName UI="Q000138" MajorTopicYN="Y">chemical synthesis</QualifierName>
                <QualifierName UI="Q000737" MajorTopicYN="Y">chemistry</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D008968" MajorTopicYN="N">Molecular Conformation</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D018716" MajorTopicYN="N">Molecular Mimicry</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D009842" MajorTopicYN="N">Oligopeptides</DescriptorName>
                <QualifierName UI="Q000138" MajorTopicYN="Y">chemical synthesis</QualifierName>
                <QualifierName UI="Q000737" MajorTopicYN="Y">chemistry</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D013237" MajorTopicYN="N">Stereoisomerism</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D018909" MajorTopicYN="N">src Homology Domains</DescriptorName>
            </MeshHeading>
        </MeshHeadingList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2007</Year>
                <Month>11</Month>
                <Day>10</Day>
                <Hour>9</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2008</Year>
                <Month>2</Month>
                <Day>21</Day>
                <Hour>9</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2007</Year>
                <Month>11</Month>
                <Day>10</Day>
                <Hour>9</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>ppublish</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">17990895</ArticleId>
            <ArticleId IdType="doi">10.1021/jo701831q</ArticleId>
            <ArticleId IdType="pmc">PMC2533429</ArticleId>
            <ArticleId IdType="mid">NIHMS64839</ArticleId>
        </ArticleIdList>
        <ReferenceList>
            <Reference>
                <Citation>Trends Biochem Sci. 1998 Apr;23(4):149-50</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">9584619</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Int J Pept Res Ther. 2006 Mar;12(1):33-48</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">19444322</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Chembiochem. 2005 Apr;6(4):668-74</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">15719347</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Org Lett. 2001 May 31;3(11):1617-20</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">11405669</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Med Chem. 2002 Aug 29;45(18):4047-54</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">12190326</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Med Chem. 2003 Jan 16;46(2):244-54</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">12519063</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Mol Biol. 2005 Oct 14;353(1):104-15</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">16165154</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Molecules. 2006;11(8):615-25</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">17971734</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Nat Struct Biol. 1996 Jul;3(7):586-9</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">8673601</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Org Biomol Chem. 2007 Jan 21;5(2):367-72</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">17205182</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Org Chem. 2001 Aug 10;66(16):5291-302</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">11485448</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Org Chem. 2000 Sep 22;65(19):6288-91</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">10987981</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Anticancer Drugs. 2006 Jan;17(1):13-20</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">16317285</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Bioorg Med Chem Lett. 2005 May 16;15(10):2461-5</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">15863297</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Org Lett. 1999 Sep 23;1(6):953-6</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">10823227</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Org Biomol Chem. 2003 Mar 21;1(6):973-7</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">12929636</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Med Chem. 1994 Nov 11;37(23):3910-7</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">7966152</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Med Chem. 2004 Jun 3;47(12):3131-41</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">15163193</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Med Chem. 2004 Apr 8;47(8):2166-9</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">15056012</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Med Chem. 2005 Feb 10;48(3):764-72</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">15689160</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
    </PubmedData>
</PubmedArticle>

</PubmedArticleSet>
